Integral Diagnostics Limited
IDX.AX
#7383
Rank
A$0.73 B
Marketcap
A$1.96
Share price
1.29%
Change (1 day)
-10.36%
Change (1 year)

P/E ratio for Integral Diagnostics Limited (IDX.AX)

P/E ratio at the end of 2025: 164

According to Integral Diagnostics Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 129.969. At the end of 2025 the company had a P/E ratio of 164.

P/E ratio history for Integral Diagnostics Limited from 2016 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2025164-1750.08%
2024-9.94-134.22%
202329.1-26.83%
202239.745.97%
202127.2-2.02%
202027.844.99%
201919.2-14.58%
201822.4104.7%
201711.0-12.02%
201612.5

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.